April 22, 2026
When AI Meets CGMP: Lessons from FDA's First Warning Letter on Non-Compliant AI ...
The FDA's warning letter to Purolea Cosmetics Lab highlights the need for rigorous AI governance in pharmaceutical manufacturing. Compliance is crucial for product quality and safety.

